Patent directory · USPTO A61K / A61P
Patents matching “Vertex Pharmaceuticals Incorporated”
980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8969386
Modulators of CFTR
granted -
US 8969574
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
granted -
US 8969356
Compounds useful as inhibitors of ATR kinase
granted -
US 8969359
Gyrase and topoisomerase IV inhibitors
granted -
US 8962856
Modulators of cystic fibrosis transmembrane conductance regulator
granted -
US 8962631
Compounds useful as inhibitors of ATR kinase
granted -
US 8962642
5-cyano-4- (pyrrolo [2,3B] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
granted -
US 8957078
Compounds useful as inhibitors of ATR kinase
granted -
US 8952050
Modulators of ATP-binding cassette transporters
granted -
US 8952049
Modulators of ATP-binding cassette transporters
granted -
US 8946425
Processes and intermediates for producing azaindoles
granted -
US 8937064
Pyrazolo[1,5-a]pyrimidines useful as JAK2 inhibitors
granted -
US 8921376
Pyrrolopyridines useful as inhibitors of protein kinase
granted -
US 8916565
Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
granted -
US 8916538
Solid forms of a thiophosphoramidate nucleotide prodrug
granted -
US 8912198
Compounds useful as inhibitors of ATR kinase
granted -
US 8912199
Modulators of ATP-binding cassette transporters
granted -
US 8912326
Process of making gyrase and topoisomerase inhibitors
granted -
US 8895723
Methods of preparing substituted nucleotide analogs
granted -
US 8895740
Pyrazolopyrazine kinase inhibitors
granted -
US 8889875
Pyridyl derivatives as CFTR modulators
granted -
US 8884018
Process for preparing modulators of cystic fibrosis transmembrane conductance regulator
granted -
US 8883766
Ion channel modulators and methods of use
granted -
US 8883206
Pharmaceutical composition and administrations thereof
granted